GlassScriptPhysician profile
Sebastian Lane
NPI 1508483785
$5,158.17
in general payments reported to CMS, 2019-2025
12 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.17 · 2022: $128 · 2023: $79.84 · 2024: $3,470 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,853 · Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,852.68 |
| Food and Beverage | $1,094.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,963.32 | 2022-2024 | |
| Integra Lifesciences Corporation | $1,622.76 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Urgo Medical North America, LLC | $166.30 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Becton, Dickinson and Company | $154.12 | 2025 | Phasix Mesh |
| Kerecis Limited | $69.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Edwards Lifesciences Corporation | $49.30 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $44.23 | 2021-2023 | V-Loc 180 |
| Acacia Pharma INC | $22.97 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.46 | 2022 | |
| Kci USA, INC. | $19.16 | 2021 | |
| Boston Scientific Corporation | $15.44 | 2021 | |
| Myriad Genetic Laboratories, INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sebastian Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.